Refine by
Disease Symptoms Suppliers & Manufacturers
56 companies found
based inBerlin, GERMANY
MerLion Pharmaceuticals is a biopharma company focusing on the research and development of drugs for the treatment of serious bacterial infections. MerLion - located in Berlin-Buch, Germany - manages the non-clinical and clinical development as well ...
based inLake Bluff, ILLINOIS (USA)
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations ...
based inMunich, GERMANY
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...
The acute SARS-CoV-2 infection is diagnosed routinely through PCR-based detection of viral RNA from nasopharyngeal swabs. Additionally, direct antigen detection of viral proteins is now available. The specific detection by PCR has a high sensitivity ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
Latiglutenase (IMGX003) is an orally administered mixture of two gluten-specific recombinant proteases that degrades gluten proteins into small physiologically irrelevant fragments, and is to be administered as an adjunct to a gluten-free diet ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential spectroscopy to detect ...
based inSchlieren, SWITZERLAND
Based on our research, we believe that the common denominator underlying each intestinal microbiome is a network of interconnected, interdependent and metabolic functions that are essential for the host and the microbiome. PharmaBiome has developed ...
Leading-edge therapies that leverage the microbiome promise to address a range of serious diseases that currently don’t have adequate solutions. Microbiome-based therapies are de-risked thanks to the established proof-of-concept with fecal ...
based inFrederick, MARYLAND (USA)
Amivas (US), LLC is an Australian, Canadian, and US joint venture focused on the development, manufacturing, and commercialization of therapeutics for the treatment of infectious diseases. Amivas (US), LLC was formed in response to the urgent need ...
based inNewton, MASSACHUSETTS (USA)
BioSensics is a global leader in development of wearable sensors and digital platforms for clinical trials, patient monitoring and health assessment. BioSensics was founded in 2007 by three scientists from Harvard University with a vision of ...
A transformative mobile health application for monitoring motor, speech and cognitive function, and mental ...
based inCleveland, OHIO (USA)
Great Lakes NeuroTechnologies is at the forefront of biomedical technology, focusing on the development of bioinstrumentation products that cater to both physiological monitoring and patient-centered diagnostics. Their expertise spans across ...
The KinesiaU™ motor assessment system serves as a clinically validated, cost-effective prescription application designed for individuals managing Parkinson’s disease and essential tremor. This innovative system is compatible with ...
based inStockholm, SWEDEN
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several ...
Microsomal prostaglandin E synthase (mPGES-1) is an enzyme generally present at low levels in the human body. It stimulates production of prostaglandin E2 (PGE2), a potent biological messenger that has a pronounced impact on inflammation. During ...
based inAbsam, AUSTRIA
From the Tyrol out into the whole world: for more than 75 years, as a family-owned pharmaceutical company in Absam now in the third generation, we have been researching, developing and producing products to help people feel well again. Our main ...
Tavipec capsules help for acute bronchitis, colds and ...
based inAarhus C, DENMARK
Cercare Medical is based on +25 years of research in perfusion imaging and artificial intelligence. Our novel biomarkers provide unparalleled patient insights. We are bridging the gap between science and clinical practice. With our amazing ...
based inChennai, INDIA
SONEL SA has existed since June 1994. The company’s founders were electrical engineers – people who had good knowledge of the market needs for specialized test equipment. In 1998 there was a change of name and legal status and as a result SONEL ...
Sonel KT-800M IR Fever Warning System can be applied to mass fever screening in crowded public places, which helps detect people with potential fever. It may contain or limit the spread of diseases through identification of infected ...
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
based inCambridge, MASSACHUSETTS (USA)
The exponential growth of biomedical data, driven by the adoption of electronic medical records (EMRs), provides an unprecedented opportunity to create transformative technologies and products in healthcare. nference partners with medical centers to ...
Our scientists use the nference platform and data in collaboration with your teams to tackle your most important questions and challenges. nference is creating the largest labeled EMR dataset in healthcare. EMR data contains longitudinal real-world, ...
based inCleveland, OHIO (USA)
about-us-imageNDI (Neuro Device Innovations) is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies. NDI pursues, funds and develops opportunities that address unmet clinical needs with ...
TOPS technology was developed by Duke University Biomedical Engineering Professor, Dr. Warren Grill. After more than a decade of research, Professor Grill's lab discovered a way to 'speak' to the area of the brain that controls movement in people ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
based inSalt Lake City, UTAH (USA)
BioFire Diagnostics sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and ...
With overlapping symptoms, distinguishing possible causes of gastroenteritis can be challenging for any clinician. To further complicate diagnosis, traditional testing methods are slow, labor intensive, and fail to reveal the etiology of a ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
BX003 is an orally administered phage cocktail targeting a bacterial target present in the gut of IBD and PSC patients and thought to be associated with the onset or exacerbation of these diseases. Although different organs are affected in IBD and ...
based inCambridge, MASSACHUSETTS (USA)
Alnylam is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life ...